Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
0.75
- 0.00 (-0.13%)
Day High: 0.78
Day Low:  0.72
Volume:    36,770
3:59 PM ET on Dec 2, 2016

Delayed at least 20 minutes.

Events & Presentations

Upcoming events are not available at this time. Sign up for email alerts.